A concise description of cardioprotective strategies in doxorubicin-induced cardiotoxicity

By Lehenbauer Ludke Ana R.   Al-Shudiefat Abd Al-Rahman S.   Dhingra Sanjiv   Jassal Davinder S.   Singal Pawan K.  

Canadian Journal of Physiology and Pharmacology, Vol. 87, Iss. 10, 2009-10 ,pp. : 756-763

NRC Research Press

Access to resources Recommend Favorite

Amelioration of doxorubicin-induced cardiotoxicity by deferiprone in rats

By Ammar El-Sayed M.   Said Shehta A.   Suddek Ghada M.   El-Damarawy Sally L.  

Canadian Journal of Physiology and Pharmacology, Vol. 89, Iss. 4, 2011-04 ,pp. : 269-276

NRC Research Press

Access to resources Recommend Favorite

Reduction of Doxorubicin-Induced Cardiotoxicity Using Nanocarriers: A Review

By  

Current Drug Metabolism, Vol. 18, Iss. 3, 2017-03 ,pp. : 237-263

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmaceutical Measures to Prevent Doxorubicin-Induced Cardiotoxicity

By  

Mini Reviews in Medicinal Chemistry, Vol. 17, Iss. 1, 2017-01 ,pp. : 44-50

Bentham Science Publishers

Access to resources Recommend Favorite

Endurance exercise attenuates cardiotoxicity induced by androgen deprivation and doxorubicin

By Parry Traci L.   Hydock David S.   Jensen Brock T.   Lien Chia-Ying   Schneider Carole M.   Hayward Reid  

Canadian Journal of Physiology and Pharmacology, Vol. 92, Iss. 5, 2014-01 ,pp. : 356-362

NRC Research Press

Access to resources Recommend Favorite